Twitter summary: FDA approves Contrave weight management drug, with potential future use in #T2D On September 10, the FDA announced the approval of Orexigen’s weight...

How a dramatic 23% increase in new diabetes cases impacts people living with diabetes nationwide.

Starting in 2012, the American Diabetes Association established the Pathway to Stop Diabetes initiative, a $1.6 million grant (paid over five years) to support the...

The latest on Medtronic’s drive to close the loop!

Can a drug long-used to treat gout be effective at preventing diabetic kidney disease?

How this “disease interception” strategy could transform our knowledge of type 1 diabetes.

Expansion of the use of Roche’s Lucentis a major step for patients.

How a single change at the FDA could lead to major improvements for patients and the healthcare system.

Why 2015 may be the “tipping point” for digital therapies in diabetes.

Praluent now approved for two specific patient populations. How this drug has the future potential to make a big impact on people with diabetes.

What does this controversial data mean for the type 2 diabetes epidemic?

Our top actionable tips for parents: straight from Friends for Life!

ADA, CDC, AMA, and the Ad Council just launched the first-ever national PSA campaign targeting prediabetes awareness and prevention - plus, three short video ads!

Diagnoses stabilizing, though 83% of 65+ year olds have diabetes or prediabetes.

Leaders in diabetes weigh in at The diaTribe Foundation’s second-annual event in Europe.

Gamechanging Xultophy (Tresiba + Victoza) also now submitted to the FDA.

Paving the way to healthier food options and preventing heart disease.

New two-year study suggests red wine is beneficial for cholesterol levels.

My somewhat-impatient response to the recent New York Times article, “Some Older Patients Are Treated Not Wisely, but Too Much.”

Major organizations make it clear: diabetes education is critical!